Stocks and Investing Stocks and Investing
Thu, February 17, 2022
[ 12:00 AM ] - United States, WOPRAI
Cecilia Furlong Maintained (ALC) at Hold with Decreased Target to $92 on, Feb 17th, 2022
Wed, February 16, 2022
[ 12:00 AM ] - United States, WOPRAI
John Newman Maintained (AGIO) at Strong Buy with Decreased Target to $44 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Roanna Ruiz Maintained (ALGS) at Buy with Decreased Target to $250 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Frank Louthan Maintained (AKAM) at Buy with Decreased Target to $118 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Fatima Boolani Maintained (AKAM) at Strong Buy with Decreased Target to $130 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Shebly Seyrafi Maintained (AKAM) at Buy with Decreased Target to $130 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Sterling Auty Maintained (AKAM) at Sell with Decreased Target to $115 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
James Fish Maintained (AKAM) at Hold with Decreased Target to $121 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Brian Peterson Maintained (ZI) at Buy with Decreased Target to $70 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Siti Panigrahi Maintained (ZI) at Strong Buy with Increased Target to $65 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Emily Chieng Maintained (AA) at Strong Buy with Increased Target to $88 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Michael Ryskin Maintained (ZTS) at Strong Buy with Decreased Target to $254 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Justin Patterson Maintained (ABNB) at Buy with Increased Target to $210 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Thomas Champion Maintained (ABNB) at Hold with Increased Target to $194 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Bernie McTernan Maintained (ABNB) at Strong Buy with Increased Target to $220 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
James Lee Maintained (ABNB) at Hold with Increased Target to $205 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Brian Nowak Maintained (ABNB) at Hold with Increased Target to $175 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Stephen Ju Maintained (ABNB) at Hold with Increased Target to $185 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Deepak Mathivanan Maintained (ABNB) at Hold with Increased Target to $170 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Colin Sebastian Maintained (ABNB) at Buy with Increased Target to $210 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Tom White Maintained (ABNB) at Strong Buy with Increased Target to $235 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Naved Khan Maintained (ABNB) at Hold with Increased Target to $190 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Simeon Gutman Maintained (AAP) at Hold with Increased Target to $240 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Steven Zaccone Maintained (AAP) at Strong Buy with Increased Target to $294 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Steven Shemesh Maintained (AAP) at Hold with Increased Target to $247 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Roanna Ruiz Maintained (AMRN) at Buy with Decreased Target to $10 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Michael Cyprys Maintained (ARES) at Hold with Increased Target to $93 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Mark Massaro Maintained (ADPT) at Strong Buy with Decreased Target to $30 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Insoo Kim Maintained (AES) at Strong Buy with Decreased Target to $27 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Colin Bristow Maintained (BTAI) at Strong Buy with Decreased Target to $25 on, Feb 16th, 2022

Colin Bristow Maintained (BTAI) at Strong Buy with Decreased Target to $25 on, Feb 16th, 2022


Published on 2024-10-27 19:42:43 - WOPRAI, Colin Bristow
  Print publication without navigation


Colin Bristow of UBS, Maintained "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy with Decreased Target from $88 to $25 on, Feb 16th, 2022.

Colin has made no other calls on BTAI in the last 4 months.



There is 1 other peer that has a rating on BTAI. Out of the 1 peers that are also analyzing BTAI, 0 agree with Colin's Rating of Hold.



This is the rating of the analyst that currently disagrees with Colin

  • Corinne Jenkins of "Goldman Sachs" Downgraded from Strong Buy to Strong Sell and Decreased Target to $24 on, Monday, November 15th, 2021

Contributing Sources